Long-Standing Statin Therapy and the Risk of New-Onset Diabetes in the Elderly: Collateral Damage Caused by Preventive Medicine?

Author： Mascitelli Luca  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.29, Iss.1, 2012-01, pp. : 9-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New ethics of medicine?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 249, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance

By  

Current Pharmaceutical Design, Vol. 19, Iss. 27, 2013-08 ,pp. : 4904-4912

Bentham Science Publishers

Access to resources Recommend Favorite

When is a Food a Medicine?

By Shaw I.  

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 2, 2003-01 ,pp. : 69-69

Adis International

Access to resources Recommend Favorite

The Long-Term Effect of Statins on the Risk of New-Onset Diabetes Mellitus in Elderly Taiwanese Patients with Hypertension and Dyslipidaemia: A Retrospective Longitudinal Cohort Study

By Tsochiang  

Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. : 45-51

Adis International

Access to resources Recommend Favorite

Reduced risk of macular degeneration with statin therapy?

By  

Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite